#may2020mccqe1
A 75-year-old woman with long-standing asthma is evaluated for a 1-month history of nocturnal asthma symptoms at least weekly and the need to use an albuterol inhaler daily. Her asthma therapy is a moderate-dose inhaled corticosteroid. The patient is otherwise healthy. On physical examination, she has occasional wheezing, but the rest of the examination is unremarkable. On office spirometry, the FEV1 is 70% of predicted and FVC is 85% of predicted. Which of the following is the most appropriate management?
(A) Adding a leukotriene-modifying agent
(B) Adding a long-acting anticholinergic agent
(C) Adding a long-acting β-agonist
(D) Adding theophylline
(E) Doubling the corticosteroid dose
A 75-year-old woman with long-standing asthma is evaluated for a 1-month history of nocturnal asthma symptoms at least weekly and the need to use an albuterol inhaler daily. Her asthma therapy is a moderate-dose inhaled corticosteroid. The patient is otherwise healthy. On physical examination, she has occasional wheezing, but the rest of the examination is unremarkable. On office spirometry, the FEV1 is 70% of predicted and FVC is 85% of predicted. Which of the following is the most appropriate management?
(A) Adding a leukotriene-modifying agent
(B) Adding a long-acting anticholinergic agent
(C) Adding a long-acting β-agonist
(D) Adding theophylline
(E) Doubling the corticosteroid dose
Last edited by a moderator: